九強生物(300406.SZ):持股5%以上股東、董事擬減持股份
格隆匯5月16日丨九強生物(300406.SZ)公佈,持有公司股份39,280,659股(佔公司有表決權股份比例爲6.72%,“公司有表決權股份”爲截至2025年5月15日收盤時總股本剔除公司回購專用賬戶中的股份數量,下同)的大股東、董事長鄒左軍先生計劃自公告披露之日起十五個交易日後的三個月內以大宗交易方式減持公司股份,計劃減持數量不超過5,160,405股(佔公司有表決權股份比例的0.88%)。
持有公司股份67,013,676股(佔公司有表決權股份比例爲11.46%)的大股東、董事劉希先生計劃自公告披露之日起十五個交易日後的三個月內以大宗交易方式減持公司股份,計劃減持數量不超過8,803,766股(佔公司有表決權股份比例的1.51%)。
持有公司股份56,977,777股(佔公司有表決權股份比例爲9.74%)的大股東、董事羅愛平先生計劃自公告披露之日起十五個交易日後的三個月內以大宗交易方式減持公司股份,計劃減持數量不超過7,485,323股(佔公司有表決權股份比例的1.28%)。
持有公司股份50,391,452股(佔公司有表決權股份比例爲8.62%)的大股東、董事孫小林先生計劃自公告披露之日起十五個交易日後的三個月內以大宗交易方式減持公司股份,計劃減持數量不超過6,620,060股(佔公司有表決權股份比例的1.13%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.